412910
Methyltrioxorhenium(VII)
Re 71.0-76.0 %, solid
Synonym(s):
MTO, Methylrhenium(VII) trioxide
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
CH3ReO3
CAS Number:
Molecular Weight:
249.24
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12161600
MDL number:
Beilstein/REAXYS Number:
3927932
Product Name
Methyltrioxorhenium(VII), Re 71.0-76.0 %
InChI
1S/CH3.3O.Re/h1H3;;;;
SMILES string
C[Re](=O)(=O)=O
InChI key
PQTLALPZRPFYIT-UHFFFAOYSA-N
form
solid
composition
Re, 71.0-76.0%
reaction suitability
core: rhenium
reagent type: catalyst
mp
111 °C (lit.)
Quality Level
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
Potent catalytic oxidant for converting alkenes to epoxides in a variety of solvents and 2-methylnaphthalene to 2-methyl-1,4-naphthoquinone (Vitamin K3).
Catalytic oxidant used with urea hydrogen peroxide in an efficient conversion of imines to nitrones.
An effective antioxidant under various conditions.
Catalytic oxidant used with urea hydrogen peroxide in an efficient conversion of imines to nitrones.
An effective antioxidant under various conditions.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Aldrichimica Acta, 28, 55-55 (1995)
Applied Homogeneous Catalysis with Organometallic Compounds, 3, 1304-1304 (2002)
R Pasquariello et al.
Theriogenology, 145, 77-85 (2020-02-01)
Developmental competence determines the oocyte capacity to support initial embryo growth, but the molecular mechanisms underlying this phenomenon are still ill-defined. Changes in microRNA (miRNA) expression pattern have been described during follicular growth in several species. Therefore, aim of this
Christina Janko et al.
International journal of molecular sciences, 14(4), 7341-7355 (2013-04-04)
Magnetic drug targeting (MDT) improves the integrity of healthy tissues and cells during treatment with cytotoxic drugs. An anticancer drug is bound to superparamagnetic iron oxide nanoparticles (SPION), injected into the vascular supply of the tumor and directed into the
Angewandte Chemie (International Edition in English), 30, 1638-1638 (1991)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service